Clinical Trial

Investıgatıon Of The Effectıveness Of The Mollıı Suıt In Chıldren Wıth Ambulatory Cerebral Palsy

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 11, 2025 (before its estimated November 5, 2025 completion). Its status may not reflect the trial's current state.
Summary
Cerebral Palsy (CP) is the most common developmental disorder in childhood. Individuals' independence in daily living activities and participation in education, games, social and community activities are restricted. Technology applications in the field of rehabilitation are gaining momentum. EXOPULSE Mollii Suit method, one of the newest rehabilitation technology products, is a non-invasive neuromodulation approach with a garment that covers the whole body and electrodes placed inside. Designed to improve motor function by reducing spasticity and pain, the method is based on the principle of reciprocal inhibition, which occurs by stimulating the antagonist of a spastic muscle at low frequencies and intensities. Therefore, the aim of our study is to examine the effectiveness of the Mollii Suit application on gross and fine motor function, spasticity severity, balance, walking, selective motor control, postural control, daily living activities, quality of life, pain and sleep quality in individuals with ambulatory spastic CP.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-10-25; most recent amendment 2025-07-08.
Trial Details
NCT Number NCT06109129
Lead Sponsor Kastamonu University
Collaborators: Gazi University
Conditions Cerebral Palsy, Spasticity, Muscle
Enrollment 32 participants
Start Date 2023-11-05
Primary Completion 2025-11-05 (estimated)
Study Completion 2025-11-05 (estimated)
Updated on ClinicalTrials.gov 2025-07-11